ReviewDrug design, development and therapy2021

Current Status and Perspectives of Protease Inhibitors and Their Combination with Nanosized Drug Delivery Systems for Targeted Cancer Therapy.

Magdalena Rudzińska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.